Five-year quality of life results of the randomized clinical phase III (RADPLAT) trial, comparing concomitant intra-arterial versus intravenous chemoradiotherapy in locally advanced head and neck cancer

Head and Neck

Volumn 34, Issue 7, 2012, Pages 974-980

  Ackerstaff, Annemieke H ^a   Rasch, Coen R N ^a   Balm, Alfons J M ^a,b   De Boer, Jan Paul ^a   Wiggenraad, Ruud ^c   Rietveld, Derek H F ^d,f   Gregor, R Theo ^e   Kröger, Robert ^a   Hauptmann, Michael ^a   Vincent, Andrew ^a   Hilgers, Frans J M ^a,b  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MEDICAL CENTER HAAGLANDEN   (Netherlands)

^d Radiotherapy Institute Friesland   (Netherlands)

^e WAIKATO HOSPITAL   (New Zealand)

^f VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Advanced head and neck cancer; Chemoradiation; Intra arterial infusion; IV infusion; Quality of life

Indexed keywords

ANALGESIC AGENT; CISPLATIN; SODIUM THIOSULFATE;

ADULT; ADVANCED CANCER; AGED; ALCOHOL CONSUMPTION; ARTICLE; CANCER CLASSIFICATION; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CANCER SURVIVOR; CHEMORADIOTHERAPY; CHEMOTHERAPY INDUCED NAUSEA AND VOMITING; COMPARATIVE STUDY; CONTROLLED STUDY; DYSPNEA; EMPLOYMENT; FATIGUE; FEMALE; FOLLOW UP; HEAD AND NECK CANCER; HEAD AND NECK PAIN; HUMAN; MAJOR CLINICAL STUDY; MALE; PAIN; PATIENT ASSESSMENT; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SMOKING; SWALLOWING; VOICE; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CHEMORADIOTHERAPY; CISPLATIN; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; INFUSIONS, INTRAVENOUS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; QUALITY OF LIFE; QUESTIONNAIRES; YOUNG ADULT;

EID: 84862901258     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.21851     Document Type: Article

References (24)

1. Balm AJ, Ackerstaff AH, Hilgers FJ, Gregor RT, Bos KE. Psychologic aspects of major head and neck reconstructive surgery. Facial Plast Surg 1995;11:91-98.
2. Ackerstaff AH, Lindeboom JA, Balm AJ, Kroon FH, Tan IB, Hilgers FJ. Structured assessment of the consequences of composite resection. Clin Otolaryngol Allied Sci 1998;23:339-344. (Pubitemid 28408396)
3. de Graeff A, De Leeuw JR, Ros WJ, Hordijk GJ, Blijham GH, Winnubst JA. Long-term quality of life of patients with head and neck cancer. Laryngoscope 2000;110:98-106. (Pubitemid 30046653)
4. List MA, Bilir SP. Functional outcomes in head and neck cancer. Semin Radiat Oncol 2004;14:178-189. (Pubitemid 38586111)
5. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-955. (Pubitemid 30148259)
6. Robbins KT, Vicario D, Seagren S, et al. A targeted supradose cisplatin chemoradiation protocol for advanced head and neck cancer. Am J Surg 1994;168:419-422. (Pubitemid 24345687)
7. Robbins KT. The evolving role of combined modality therapy in head and neck cancer. Arch Otolaryngol Head Neck Surg 2000;126:265-269. (Pubitemid 30140377)
8. Balm AJ, Rasch CR, Schornagel JH, et al. High-dose superselective intraarterial cisplatin and concomitant radiation (RADPLAT) for advanced head and neck cancer. Head Neck 2004; 26:485-493. (Pubitemid 38702635)
9. Rasch CR, Hauptmann M, Schornagel J, et al. Intra-arterial versus intravenous chemoradiation for advanced head and neck cancer: results of a randomized phase 3 trial. Cancer 2010; 116:2159-2165.
10. Ackerstaff AH, Tan IB, Rasch CR, et al. Quality-of-life assessment after supradose selective intra-arterial cisplatin and concomitant radiation (RADPLAT) for inoperable stage IV head and neck squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 2002;128:1185-1190. (Pubitemid 35168110)
11. Ackerstaff AH, Balm AJ, Rasch CR, et al. First-year quality of life assessment of an intra-arterial (RADPLAT) versus intravenous chemoradiation phase III trial. Head Neck 2009;31:77-84.
12. Goldstein DP, Hynds Karnell L, Christensen AJ, Funk GF. Health-related quality of life profiles based on survivorship status for head and neck cancer patients. Head Neck 2007;29:221-229. (Pubitemid 46339318)
13. Klug C, Neuburg J, Glaser C, Schwarz B, Kermer C, Millesi W. Quality of life 2-10 years after combined treatment for advanced oral and oropharyngeal cancer. Int J Oral Maxillofac Surg 2002;31:664-669.
14. Hammerlid E, Silander E, Hornestam L, Sullivan M. Health-related quality of life three years after diagnosis of head and neck cancer: a longitudinal study. Head Neck 2001;23:113-125. (Pubitemid 32060662)
15. Morton RP. Studies in the quality of life of head and neck cancer patients: results of a two-year longitudinal study and a comparative cross-sectional cross-cultural survey. Laryngoscope 2003;113:1091-1103. (Pubitemid 36835552)
16. Mehanna HM, Morton RP. Deterioration in quality-of-life of late (10- year) survivors of head and neck cancer. Clin Otolaryngol 2006;31: 204-211. (Pubitemid 43823416)
17. Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85:365-376. (Pubitemid 23073154)
18. Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999;17:1008-1019. (Pubitemid 29109335)
19. Op de Coul BMR, Ackerstaff AH, van As CJ, et al. Quality of life assessment in laryngectomized individuals: do we need additions to standard questionnaires in specific clinical research projects? Clin Otolaryngol 2005;30:169-175. (Pubitemid 40559447)
20. Kreeft A, Tan IB, van den Brekel MW, Hilgers FJ, Balm AJ. The surgical dilemma of "functional inoperability" in oral and oropharyngeal cancer: current consensus on operability with regard to functional results. Clin Otolaryngol 2009;34:140-146.
21. Ringash J, Warde P, Lockwood G, O'Sullivan B, Waldron J, Cummings B. Postradiotherapy quality of life for head-and-neck cancer patients is independent of xerostomia. Int J Radiat Oncol Biol Phys 2005;61: 1403-1407. (Pubitemid 40470421)
22. Logemann JA, Pauloski BR, Rademaker AW, et al. Swallowing disorders in the first year after radiation and chemoradiation. Head Neck 2008;30: 148-158. (Pubitemid 351251697)
23. Jacobi I, van der Molen L, Huiskens H, van Rossum MA, Hilgers FJ. Voice and speech outcomes of chemoradiation for advanced head and neck cancer: a systematic review. Eur Arch Otorhinolaryngol 2010;267: 1495-1505.
24. Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. J Am Med Assoc 2005;294:1505-1510. (Pubitemid 41362687)